STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Cellebrite DI Ltd. Warrants SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for CLBTW (Cellebrite DI Ltd.) discloses a proposed sale of 2,814 common shares, with an aggregate market value of $44,461.20, to be executed on 08/20/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filing shows the shares were acquired by the reporting person from the issuer as follows: 1,087 shares via exercise of stock options on 08/20/2025 with cash payment, and 1,727 shares delivered as restricted stock units on 08/06/2025. The filing reports 244,469,106 shares outstanding for the class and indicates no securities sold in the past three months by the reporting person.

Positive
  • Transparent disclosure of planned sale details including broker, share counts, acquisition dates, and payment method
  • No sales in prior three months reported, clarifying aggregation under Rule 144
Negative
  • None.

Insights

TL;DR: Routine insider sale notice showing option exercise and RSU delivery ahead of a small planned sale, properly routed through a broker.

The notice documents a proposed sale under Rule 144 of 2,814 common shares valued at $44,461.20, to be executed on NASDAQ via Morgan Stanley Smith Barney LLC. The acquisition detail separates option exercise (1,087 shares) and RSU vesting/delivery (1,727 shares), with cash payment recorded for the exercised options. The filing states no sales in the prior three months, which supports aggregation rules for Rule 144. From a compliance perspective, the form includes the core elements required for a Rule 144 notice: class, broker, amounts, acquisition dates and nature, payment method, and planned sale date.

TL;DR: Disclosure is orderly and clear but reflects routine insider liquidity following option exercise and RSU delivery.

The filing signals a small insider liquidity event relative to the reported 244,469,106 outstanding shares. The split between option exercise and RSU issuance is explicitly stated, and the broker information is provided. No prior three-month sales are reported, which means these shares are not aggregated with recent disposals. The document contains the standard attestation language about material nonpublic information. No governance concerns are evident from the filing alone.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares does the CLBTW Form 144 propose to sell?

The notice proposes sale of 2,814 common shares with an aggregate market value of $44,461.20.

When and where is the CLBTW sale planned to occur?

The proposed sale date is 08/20/2025 on NASDAQ through Morgan Stanley Smith Barney LLC.

How were the shares acquired that are being sold under Form 144?

The filer acquired 1,087 shares by exercising stock options on 08/20/2025 (paid in cash) and 1,727 shares as restricted stock units on 08/06/2025.

Does the filing report any securities sold by the person in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

How many shares outstanding are reported for the class in this filing?

The filing reports 244,469,106 shares outstanding for the common class.
Cellebrite Di Ltd

NASDAQ:CLBTW

CLBTW Rankings

CLBTW Latest News

CLBTW Latest SEC Filings

CLBTW Stock Data

203.23M
Software - Infrastructure
Technology
Link
Israel
Petah Tikva